Technical brief |

COVID-19 Vaccine Global Access (COVAX) Facility: Key considerations for Gavi’s new global financing mechanism


As an international medical humanitarian organisation, MSF seeks to ensure that the medical tools urgently needed to respond to COVID-19 are accessible, affordable and available to all countries and vulnerable populations equitably. Overwhelmingly, global health leaders have agreed that potential future COVID-19 vaccines must be considered a “global public good” and “the people’s vaccine.”

This briefing document presents some of MSF’s concerns around access for future COVID-19 vaccines and a new global financing mechanism coordinated by Gavi, the Vaccine Alliance, called the COVID-19 Vaccine Global Access (COVAX) Facility. This document offers MSF’s perspective on key considerations and next steps that Gavi, partners and potential funders of the COVAX Facility should undertake to support the development and delivery of COVID-19 vaccines that are accessible and affordable for everyone.

Read MSF Access Campaign’s press release for Gavi’s 4 June 2020 funding replenishment meeting related to COVID-19 vaccine access.